Awaiting development: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Type |
|---|---|
| Ritlecitinib for treating non-segmental vitiligo in people 12 years and over [ID6584] | Technology appraisal guidance |
| Title | Type |
|---|---|
| Ritlecitinib for treating non-segmental vitiligo in people 12 years and over [ID6584] | Technology appraisal guidance |